Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage.
Ludwig
W D
WD
Department of Hematology/Oncology, Free University of Berlin, FRG.
Thiel
E
E
Bartram
C R
CR
Kranz
B R
BR
Raghavachar
A
A
Löffler
H
H
Ganser
A
A
Büchner
T
T
Hiddemann
W
W
Heil
G
G
D000328:Adult; D000367:Age Factors; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002454:Cell Differentiation; D002648:Child; D015329:Gene Rearrangement, T-Lymphocyte; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000145:classification* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D015337:Multicenter Studies as Topic; D014411:Neoplastic Stem Cells / Q000473:pathology*; D015996:Survival Rate; D013601:T-Lymphocytes / Q000473:pathology*
D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm